Skip to main content

Advertisement

Fig. 3 | Malaria Journal

Fig. 3

From: Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo

Fig. 3

In vivo efficacy of T5, bestatin and chloroquine against P. c. chabaudi infection in mice. Female BALB/c mice infected with P. c. chabaudi 864VD at day 0 were treated daily for 4 days (0–3) with: vehicle only (a), 100 mg/kg of bestatin (b), 12 mg/kg of T5 (c), 24 mg/kg of T5 (d) or 5 mg/kg chloroquine (e). D.p.i. is days post-infection, n = 6 mice per group

Back to article page